FDA official says UniQure fell short on Huntington's trial, defends new study request - Reuters
FDA official says UniQure fell short on Huntington's trial, defends new study request Reuters
2 stories found
FDA official says UniQure fell short on Huntington's trial, defends new study request Reuters
UniQure slides after FDA says trial data insufficient for brain disorder therapy filing TradingView